Search alternatives:
developments » development (Expand Search)
Showing 5,081 - 5,100 results of 5,343 for search 'registration developments', query time: 0.15s Refine Results
  1. 5081
  2. 5082
  3. 5083

    The first generic tirzepatide GP30931: physicochemical and biological similarity to the reference drug by I. A. Lugovik, A. V. Babina, S. S. Arutyunyan, D. О. Ermolaeva, V. B. Saparova, T. N. Kobeleva, P. G. Zaikin, A. D. Mikushina, A. S. Bukatin, I. E. Eliseev, B. Ts. Zajchik, Y. S. Keruchenko, I. S. Ohrimenko, E. V. Bocharov, A. Kh. Taldaev, V. A. Lushpa, I. E. Makarenko, R. V. Drai

    Published 2025-06-01
    “…The obtained data make a significant contribution to the scientific substantiation of the equivalence of the reproduced drug tirzepatide and the reference original drug, thereby providing a reliable basis for further registration and clinical use of Sejaro® without conducting additional clinical studies.…”
    Get full text
    Article
  4. 5084
  5. 5085
  6. 5086

    The anti-circumsporozoite antibody response to repeated, seasonal booster doses of the malaria vaccine RTS,S/AS01E by M. Sanni Ali, Lisa Stockdale, Issaka Sagara, Issaka Zongo, Rakiswendé Serge Yerbanga, Almahamoudou Mahamar, Frédéric Nikièma, Amadou Tapily, Frédéric Sompougdou, Modibo Diarra, Duncan Bellamy, Samuel Provstgaard-Morys, Charles Zoungrana, Djibrilla Issiaka, Alassane Haro, Koualy Sanogo, Abdoul Aziz Sienou, Mahamadou Kaya, Seydou Traore, Oumar M. Dicko, Youssouf Kone, Hama Yalcouye, Ismaila Thera, Kalifa Diarra, Paul Snell, Opokua Ofori-Anyinam, Chris Ockenhouse, Cynthia Lee, Katie Ewer, Halidou Tinto, Abdoulaye Djimde, Jean-Bosco Ouedraogo, Alassane Dicko, Daniel Chandramohan, Brian Greenwood

    Published 2025-02-01
    “…Anti-CSP antibody titres were measured in sera obtained from a randomly selected subset of children enrolled in this trial collected before and one month after three priming and four annual booster doses of vaccine using the GSK ELISA developed at the University of Ghent and, in a subset of these samples, by a multiplex assay developed at the University of Oxford. …”
    Get full text
    Article
  7. 5087
  8. 5088

    Effects of sedatives on diaphragm activity monitored by ultrasound: a systematic review and meta-analysis by Jiaren Luo, Luhao Wang, Bilin Wei, Zhikun Huang, Huifang Zheng, Bin Gu, Fei Pei, Zenan Chang, Yang Liu, Xiangdong Guan, Xuyu Zhang, Zimeng Liu

    Published 2025-07-01
    “…The strength of evidence was assessed using the Grades of Recommendation, Assessment, Development, and Evaluation (GRADE) Pro Guideline Development Tool (GDT). …”
    Get full text
    Article
  9. 5089

    Effects of nutritional intervention strategies in the primary prevention of overweight and obesity in school settings: systematic review and network meta-analysis by Joerg J Meerpohl, Lukas Schwingshackl, Guido Schwarzer, Jürgen M Steinacker, Edris Nury, Blin Nagavci, Georg Hoffmann, Jakub Morze, Janine Wendt, Julia Stadelmaier, Kathrin Grummich, Claudia M Angele, Johanna Conrad, Daniela Schmid

    Published 2022-12-01
    “…The results of the network meta-analysis could be used by policy makers in developing and implementing effective, evidence based nutritional intervention strategies in the school setting.Systematic review registration PROSPERO CRD42020220451.…”
    Get full text
    Article
  10. 5090
  11. 5091

    Urolithin A supplementation to improve endothelial and cerebrovascular function in middle-aged adults with obesity: Study protocol for a double-blind placebo-controlled randomized... by Ana Clara da C. Pinaffi-Langley, Camila B. Pinto, Zsofia Szarvas, Anna Peterfi, Zalan Kaposzta, Peter Mukli, Mihaly Muranyi, Cameron D. Owens, Cheryl Adams, Ali Shahriari, Henry Kinnard, Jr., Bryan Ticer, Leah Anderson, Stefano Tarantini, Yan Daniel Zhao, Norman G. Hord, Andriy Yabluchanskiy

    Published 2025-06-01
    “…Summary: Background & Aims: Obesity-related mitochondrial dysfunction initiates and exacerbates endothelial dysfunction, which in turn contributes to the development of several diseases, such as cardiovascular disease and cognitive impairment. …”
    Get full text
    Article
  12. 5092
  13. 5093

    Influence of social determinants on lifestyle modification adherence in people with prediabetes: a sequential explanatory mixed-methods study protocol by Ana Carvalho-Azevedo, Ana Carvalho-Azevedo, Ana Carvalho-Azevedo, Manuela Abbate, Manuela Abbate, Manuela Abbate, Sergio Fresneda, Sergio Fresneda, Sergio Fresneda, María Arias-Fernández, María Arias-Fernández, María Arias-Fernández, Marina Torres-Carballo, Marina Torres-Carballo, Aina M. Yañez, Aina M. Yañez, Aina M. Yañez, Aina M. Yañez, Aina M. Yañez, Cristina Moreno-Mulet, Cristina Moreno-Mulet, Cristina Moreno-Mulet, Miquel Bennasar-Veny, Miquel Bennasar-Veny, Miquel Bennasar-Veny, Miquel Bennasar-Veny, Miquel Bennasar-Veny

    Published 2025-07-01
    “…Our study can guide the development of health interventions tailored to individuals with prediabetes, focusing on addressing social disparities in lifestyle modification.Patient or public contributionParticipants will contribute through semi-structured interviews and discussion groups, providing insights into their experiences on adherence to lifestyle changes.Clinical trial registrationClinicalTrials.gov, identifier NCT06488677.…”
    Get full text
    Article
  14. 5094
  15. 5095
  16. 5096
  17. 5097
  18. 5098

    Study protocol for the BRAIN Training Trial: a randomised controlled trial of Balance, Resistance, And INterval training on cognitive function in older adults with mild cognitive i... by Teresa Liu-Ambrose, Ulrik Wisløff, Maria Fiatarone Singh, Yorgi Mavros, Perminder S Sachdev, Ryan S Falck, Dorthe Stensvold, Jeff S Coombes, Trinidad Valenzuela, Nicole Kochan, Wei Wen, Jeffrey Hausdorff, Jiyang Jiang, Emily C Smith, Matthew Hollings, Tess C Hawkins, Nicholas J Ashley, Natan Feter, Guy C Wilson, Isabel Hui En Shih, Yareni Guerrero, Tom Bailey

    Published 2022-12-01
    “…Dissemination will be via publications, conference presentations, newsletter articles, social media, talks to clinicians and consumers and meetings with health departments/managers.It is expected that communication of results will allow for the development of more effective evidence-based exercise prescription guidelines in this population while investigating the benefits of HIIT and POWER on subclinical markers of disease.Trial registration number ACTRN12617001440314 Australian New Zealand Clinical Trials Registry.…”
    Get full text
    Article
  19. 5099
  20. 5100